Vendeur : World of Books (was SecondSale), Montgomery, IL, Etats-Unis
EUR 5,68
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Acceptable. Item in acceptable condition! Textbooks may not include supplemental items i.e. CDs, access codes etc.
Vendeur : Better World Books: West, Reno, NV, Etats-Unis
Edition originale
EUR 6,18
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Vendeur : Better World Books, Mishawaka, IN, Etats-Unis
Edition originale
EUR 6,18
Quantité disponible : 2 disponible(s)
Ajouter au panierEtat : Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Vendeur : ThriftBooks-Phoenix, Phoenix, AZ, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Reno, Reno, NV, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Atlanta, AUSTELL, GA, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Phoenix, Phoenix, AZ, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Atlanta, AUSTELL, GA, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Good. No Jacket. Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.
Vendeur : ThriftBooks-Dallas, Dallas, TX, Etats-Unis
EUR 6,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Langue: anglais
Edité par Michael Terence Publishing, 2022
ISBN 10 : 1800943210 ISBN 13 : 9781800943216
Vendeur : WeBuyBooks, Rossendale, LANCS, Royaume-Uni
EUR 3,74
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned.
Vendeur : GoldBooks, Denver, CO, Etats-Unis
EUR 24,39
Quantité disponible : 1 disponible(s)
Ajouter au panierPaperback. Etat : new. New Copy. Customer Service Guaranteed.
Vendeur : Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Allemagne
Membre d'association : GIAQ
EUR 15,28
Quantité disponible : 2 disponible(s)
Ajouter au panierHardcover. Etat : Wie neu. 138 S., Like new. Shrink wrapped. / Wie neu. In Folie verschweißt. Sprache: Englisch Gewicht in Gramm: 570.
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
EUR 60,62
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. In.
Langue: anglais
Edité par Springer-Verlag 2002-01-01, 2002
ISBN 10 : 8847022363 ISBN 13 : 9788847022362
Vendeur : Chiron Media, Wallingford, Royaume-Uni
EUR 56,54
Quantité disponible : 10 disponible(s)
Ajouter au panierPaperback. Etat : New.
EUR 83,95
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. pp. x + 128.
EUR 76,85
Quantité disponible : 2 disponible(s)
Ajouter au panierPaperback. Etat : Brand New. reprint edition. 138 pages. 8.98x5.98x0.31 inches. In Stock.
EUR 50,25
Quantité disponible : 5 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Primary Progressive Multiple Sclerosis | M. Filippi (u. a.) | Taschenbuch | Topics in Neuroscience | x | Englisch | 2012 | Springer | EAN 9788847022362 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
EUR 58,39
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - 'Why are there no effective treatments for my condition Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. ' Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin ical trials have excluded PPMS patients on two counts. Clinical worsening devel ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi ence suggests that the results may not be dramatic.
EUR 118,93
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. x + 128.
EUR 120,57
Quantité disponible : 1 disponible(s)
Ajouter au panierEtat : New. pp. x + 128.
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
EUR 167,07
Quantité disponible : 1 disponible(s)
Ajouter au panierHardcover. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
EUR 46,22
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : new. Questo è un articolo print on demand.
Vendeur : Majestic Books, Hounslow, Royaume-Uni
EUR 83,85
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. Print on Demand pp. x + 128.
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
EUR 83,51
Quantité disponible : 4 disponible(s)
Ajouter au panierEtat : New. PRINT ON DEMAND pp. x + 128.
Vendeur : moluna, Greven, Allemagne
EUR 48,37
Quantité disponible : Plus de 20 disponibles
Ajouter au panierEtat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The book represents an updated report of the most recent advances in primary progressive multiple sclerosisThe book represents an updated report of the most recent advances in primary progressive multiple sclerosis Why are there no effective .
Langue: anglais
Edité par Springer, Springer Mär 2012, 2012
ISBN 10 : 8847022363 ISBN 13 : 9788847022362
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
EUR 53,49
Quantité disponible : 1 disponible(s)
Ajouter au panierTaschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -'Why are there no effective treatments for my condition Why do researchers exclude patients with primary progressive multiple sclerosis from enrolling in clinical trials Please let me know if you hear of studies that I might be allowed to enter or treatments that I could try for my condition. ' Thus, in recent years, the sad lament of the patient with primary progressive MS (PPMS). This variant, often in the guise of a chronic progressive myelopathy or, less commonly, progressive cerebellar or bulbar dysfunction, usually responds poorly to corticosteroids and rarely seems to benefit to a significant degree from intensive immunosuppressive treatments. In recent years, most randomized clin ical trials have excluded PPMS patients on two counts. Clinical worsening devel ops slowly in PPMS and may not be recognized during the course of a 2-or 3-year trial even in untreated control patients. This factor alone adds to the potential for a type 2 error or, at the very least, inflates the sample size and duration of the trial. In addition, there is mounting evidence that progressive axonal degeneration and neuronal loss (rather than active, recurrent inflammation) may be important components of the pathology in this form of the disease. Although contemporary trials are evaluating whether PPMS patients may benefit from treatment with the ~-interferons and glatiramer acetate, preliminary, uncontrolled clinical experi ence suggests that the results may not be dramatic.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 140 pp. Englisch.